ArbiLayer
VENOM logo

Venom

VENOM Rank #746
$0.012▲ 2.61%24h
Low $0.0112High $0.0121

Price chart

Loading price history…
Market cap$27.79MRank #746
Fully diluted value$88.40M
Volume (24h)$2.0KVol / Mcap 0.01%
Circulating supply2.32B29.0% of max
Total supply7.37B
Max supply8.00B
All-time high$0.7824Mar 25, 2024
All-time low$0.007669Jul 28, 2026

What is Venom?

Chain architecture

The masterchain coordinates the network's configuration and validator elections. Workchains provide the environments in which applications and transactions operate. Shardchains divide workloads within those workchains. Dynamic sharding changes that division as demand changes. This architecture allows transaction processing to be distributed across multiple parts of the network. Messages connect activity between chains.

Validation

Venom combines proof of stake with Byzantine fault-tolerant consensus. Validators participate in the agreement process that finalises transactions. The network organises validator responsibilities across the masterchain and shardchains. Smart contracts run in the TON Virtual Machine environment. That execution model is separate from Ethereum's EVM.

Native asset

VENOM covers transaction and smart contract execution charges. Validators stake it to support network security. DePools allow other holders to participate through pooled delegation. The asset uses nine decimal places. Its smallest accounting unit is called nanoVENOM.

Where to trade VENOM

2 exchanges · top 10

All 2 markets
#ExchangePairsVolume (24h)
1KuCoinCEXVENOM / USDT$2.0KTrade ↗
2GateCEXVENOM / USDT$6.7KTrade ↗
Live spot quotes from connected exchanges
VenueBidAskMidStatus
Open to load live quotes.

VENOM funding rates

Live perpetual funding on every connected exchange. Positive = longs pay shorts.

Full view

Contracts & chains

Exact contract or mint per network — the identity layer used for DEX routing.

Resolving token registry…

On-chain routes

Networks with a connected DEX routing adapter.

Loading DEX coverage…

Venom news

All news
Loading related headlines…